Evidence map›Paper›PMID 30204866›Full record

ReviewEndocrinology2018

Scaffold Proteins: From Coordinating Signaling Pathways to Metabolic Regulation.

Yves Mugabo, Gareth E Lim

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Engineering signalling pathways in mammalian cells.Nature biomedical engineering · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yves MugaboCardiometabolic Axis, Centre de Recherche de Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Gareth E LimCardiometabolic Axis, Centre de Recherche de Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Centre Hospitalier de l’Université de Montréal · CA

Funding

CIHR PJT-153144
6 · The paper itself

Abstract

Among their pleiotropic functions, scaffold proteins are required for the accurate coordination of signaling pathways. It has only been within the past 10 years that their roles in glucose homeostasis and metabolism have emerged. It is well appreciated that changes in the expression or function of signaling effectors, such as receptors or kinases, can influence the development of chronic diseases such as diabetes and obesity. However, little is known regarding whether scaffolds have similar roles in the pathogenesis of metabolic diseases. In general, scaffolds are often underappreciated in the context of metabolism or metabolic diseases. In the present review, we discuss various scaffold proteins and their involvement in signaling pathways related to metabolism and metabolic diseases. The aims of the present review were to highlight the importance of scaffold proteins and to raise awareness of their physiological contributions. A thorough understanding of how scaffolds influence metabolism could aid in the discovery of novel therapeutic approaches to treat chronic conditions, such as diabetes, obesity, and cardiovascular disease, for which the incidence of all continue to increase at alarming rates.

Indexed as

AdiposityAnimalsApoptosisBlood GlucoseCardiovascular DiseasesDiabetes MellitusEnergy MetabolismGluconeogenesisHomeostasisHumansInsulin ResistanceInsulin SecretionMetabolic DiseasesNuclear Matrix-Associated ProteinsObesitySignal TransductionBlood GlucoseNuclear Matrix-Associated Proteins

Identifiers

PMID30204866
PMCPMC6180900
OpenAlexW2891407926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.